Skip to content

Examination of the Frequency and Risk Factors of Insulin Therapy-Related Indurations

Examination of the Frequency and Risk Factors of Insulin Therapy-Related Indurations - CSII-LH study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053425
Enrollment
200
Registered
2024-01-24
Start date
2024-01-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

None listed

Sponsors

National Hospital Organization Kyoto Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Age 4 and above 2)Type 1 diabetes

Exclusion criteria

Exclusion criteria: 1)Not undergoing insulin therapy (CSII or MDI)

Design outcomes

Primary

MeasureTime frame
The objective of this study is to elucidate the frequency and risk factors associated with indurations in individuals with type 1 diabetes using insulin pumps, in comparison with those who do not use pumps.

Countries

Japan

Contacts

Public ContactNaoki Sakane

National Hospital Organization Kyoto Medical Center Division of Preventive Medicine, Clinical Research Institute

404-j-doit1@mail.hosp.go.jp075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026